GO:0032695 negative regulation of interleukin-12 production: Immune Suppression Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032695 describes any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.
• IL-12 is a heterodimeric cytokine critical for Th1 differentiation and cell-mediated immunity, and its production must be tightly controlled to avoid immunopathology.
• Negative regulation of IL-12 production is mediated by multiple mechanisms, including SOCS1-dependent inhibition of IL-12 signaling, PI3K-mediated feedback, and rapamycin-sensitive pathways.
• Dysregulation of IL-12 suppression contributes to autoimmune diseases, chronic infections, and cancer immune evasion.
• Key genes involved include SOCS1, PIK3CD, MTOR, SH2B3/LNK, and TGFB1, which modulate IL-12 production at transcriptional and post-transcriptional levels.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of these regulators in immune cells.
Description
Interleukin-12 (IL-12) is a pivotal cytokine that bridges innate and adaptive immunity by inducing interferon-gamma production and promoting T helper 1 (Th1) cell differentiation. While essential for host defense against intracellular pathogens, uncontrolled IL-12 production can lead to chronic inflammation and tissue damage. Therefore, negative regulation of interleukin-12 production (GO:0032695) is a critical biological process that maintains immune homeostasis. This GO term encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of IL-12 production, including transcriptional repression, post-transcriptional modifications, and inhibition of secretion. Understanding this process is vital for researchers studying autoimmune diseases, cancer immunology, and infectious diseases, as manipulating IL-12 levels holds therapeutic potential. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the mechanisms, genes, and research methods associated with GO:0032695.
negative regulation of interleukin-12 production At A Glance
| GO ID | GO:0032695 |
|---|---|
| GO term | negative regulation of interleukin-12 production |
| Ontology | biological_process |
| Synonym | inhibition of interleukin-12 production; downregulation of interleukin-12 production; negative regulation of IL-12 production; negative regulation of interleukin-12 biosynthetic process; negative regulation of interleukin-12 secretion; negative regulation of CLMF production; negative regulation of NKSF production |
| Major function | Suppression of IL-12 cytokine production to prevent excessive Th1 responses and immunopathology |
| Related processes | Regulation of cytokine production, TLR signaling, PI3K-Akt signaling, JAK-STAT signaling |
| Key regulators | SOCS1, PIK3CD, MTOR, SH2B3/LNK, TGFB1 |
| Disease relevance | Autoimmunity, chronic inflammation, cancer, hypertension |
What Is GO:0032695?
GO:0032695, negative regulation of interleukin-12 production, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production. This biological process includes the negative regulation of IL-12 biosynthetic process and IL-12 secretion, and is synonymous with inhibition of IL-12 production, downregulation of IL-12 production, and negative regulation of CLMF or NKSF production.
Why Is negative regulation of interleukin-12 production Important in Cell Biology?
Negative regulation of interleukin-12 production is essential for preventing excessive inflammation and autoimmunity while allowing effective pathogen clearance. Dysregulation of this process is implicated in a wide range of diseases, from inflammatory bowel disease to cancer and hypertension. Understanding the molecular players and pathways that suppress IL-12 production provides opportunities for therapeutic intervention, such as targeting SOCS1 or PI3K to modulate immune responses. Moreover, this process is a key node in the crosstalk between innate and adaptive immunity, making it a focal point for vaccine adjuvant development and immunotherapy.
• Prevents immunopathology by limiting excessive Th1 responses and IFN-gamma production.
• Maintains immune tolerance and prevents autoimmune diseases such as colitis and arthritis.
• Modulates host defense against intracellular pathogens by balancing inflammation.
• Influences cancer immunosurveillance and tumor immune evasion.
• Regulates vaccine-induced immunity and adjuvant efficacy.
• Involved in metabolic and cardiovascular diseases, including hypertension.
• Provides targets for anti-inflammatory drug development, such as rapamycin.
• Key for understanding cytokine storm syndromes and sepsis.
• Essential for dendritic cell maturation and antigen presentation.
• Contributes to the pathogenesis of chronic inflammatory diseases like psoriasis.
What Happens During negative regulation of interleukin-12 production?
Initiation by Pattern Recognition Receptors and Cytokines
In simple terms: The process starts when immune cells receive signals that trigger a need to dampen IL-12 production.
Negative regulation of IL-12 production is initiated in response to various stimuli, including Toll-like receptor (TLR) ligands, cytokines such as TGF-beta, and intracellular signals. For example, TGF-beta produced by regulatory T cells can suppress IL-12 production in dendritic cells and macrophages. Additionally, engagement of certain TLRs can paradoxically activate negative feedback pathways to prevent excessive IL-12 release.
PI3K-Mediated Feedback Inhibition
In simple terms: A signaling pathway called PI3K acts as a brake on IL-12 production after it is activated.
Phosphoinositide 3-kinase (PI3K) plays a central role in negative feedback regulation of IL-12 production in dendritic cells. Upon TLR stimulation, PI3K is activated and leads to the inhibition of IL-12 production, partly through the activation of Akt and mTOR. This pathway ensures that IL-12 responses are transient and self-limiting, preventing excessive inflammation.
SOCS1-Dependent Inhibition of IL-12 Signaling
In simple terms: SOCS1 is a protein that blocks the signals that would otherwise boost IL-12 production.
Suppressor of cytokine signaling 1 (SOCS1) is a key negative regulator of IL-12 signaling. SOCS1 is induced by cytokines such as IFN-gamma and IL-12 itself, and it inhibits the JAK-STAT pathway downstream of the IL-12 receptor, thereby reducing IL-12 production and responsiveness. This creates a negative feedback loop that limits Th1 polarization.
Rapamycin-Sensitive Pathway
In simple terms: The drug rapamycin can block a pathway that normally suppresses IL-12 production, showing that mTOR is involved.
A rapamycin-sensitive signaling pathway negatively regulates IL-12 production. Inhibition of mTOR by rapamycin enhances IL-12 production, indicating that mTOR normally suppresses IL-12. This pathway is distinct from PI3K-mediated feedback and highlights the complexity of IL-12 regulation.
Transcriptional and Post-Transcriptional Control
In simple terms: IL-12 production can be turned down by controlling gene expression or mRNA stability.
Negative regulation of IL-12 production occurs at multiple levels, including transcriptional repression and post-transcriptional modifications. For instance, the transcription factor SH2B3/LNK has been shown to modulate IL-12 production, and a single nucleotide polymorphism in SH2B3/LNK is associated with hypertension and altered immune responses. Additionally, microRNAs and RNA-binding proteins can destabilize IL-12 mRNA, reducing protein output.
Key Genes Involved in GO:0032695 negative regulation of interleukin-12 production
The following genes and proteins are central to the negative regulation of interleukin-12 production, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOCS1 | Inhibits IL-12 signaling via JAK-STAT blockade | Key negative feedback regulator; knockout mice develop severe inflammation |
| PIK3CD | PI3K catalytic subunit mediating feedback inhibition of IL-12 | Target for modulating dendritic cell responses |
| MTOR | Rapamycin-sensitive kinase that suppresses IL-12 production | Link between metabolism and immune regulation |
| SH2B3/LNK | Adaptor protein that negatively regulates cytokine signaling | SNP associated with hypertension and immune dysregulation |
| TGFB1 | Cytokine that suppresses IL-12 production | Mediates regulatory T cell effects |
| IL12A | Subunit of IL-12; its production is regulated | Target of negative regulation |
| IL12B | Subunit of IL-12; its production is regulated | Target of negative regulation |
| JAK2 | Kinase downstream of IL-12 receptor; inhibited by SOCS1 | Component of IL-12 signaling |
| STAT4 | Transcription factor activated by IL-12; feedback regulated | Mediates Th1 differentiation |
| IFNG | Cytokine induced by IL-12; can induce SOCS1 | Part of negative feedback loop |
| TLR4 | Pattern recognition receptor that triggers IL-12 and feedback | Initiates PI3K-mediated inhibition |
| MYD88 | Adaptor in TLR signaling; modulates IL-12 production | Involved in negative regulation |
| TRAF6 | E3 ubiquitin ligase in TLR signaling; can activate PI3K | Links TLR to negative feedback |
| AKT1 | Kinase downstream of PI3K; inhibits IL-12 production | Effector of PI3K pathway |
| FOXO3 | Transcription factor inhibited by Akt; may regulate IL-12 | Potential mediator of PI3K effects |
| NFKB1 | Transcription factor that can be suppressed by negative regulators | Controls IL-12 gene expression |
| IRF1 | Transcription factor for IL-12; negatively regulated | Target of suppression |
| GATA3 | Transcription factor that can suppress IL-12 in Th2 cells | Cell-type specific regulation |
How Is negative regulation of interleukin-12 production Regulated?
The negative regulation of interleukin-12 production is itself tightly regulated by multiple signaling pathways. The PI3K-Akt-mTOR axis is a major negative feedback loop: TLR engagement activates PI3K, which via Akt and mTOR suppresses IL-12 production. SOCS1 is induced by IFN-gamma and IL-12, and it inhibits JAK-STAT signaling downstream of the IL-12 receptor, reducing both IL-12 responsiveness and production. Additionally, TGF-beta signaling through Smad proteins can directly repress IL-12 transcription. The rapamycin-sensitive pathway further highlights the role of mTOR in limiting IL-12 production. These regulatory layers ensure that IL-12 responses are balanced and self-limiting.
negative regulation of interleukin-12 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOCS1 | Inflammatory bowel disease, autoimmunity | SOCS1 knockout mice; colitis models |
| PIK3CD | Cancer immune evasion, immunodeficiency | PIK3CD knock-in mice; tumor models |
| SH2B3/LNK | Hypertension, renal damage | SH2B3 SNP knock-in mice; hypertension models |
| TGFB1 | Fibrosis, autoimmunity | TGFB1 transgenic mice; colitis models |
| MTOR | Autoimmunity, cancer | mTOR conditional knockout; rapamycin treatment |
Autoimmune and Inflammatory Diseases
Defective negative regulation of IL-12 production leads to excessive Th1 responses and chronic inflammation, contributing to autoimmune diseases such as inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis. For example, SOCS1 deficiency in mice results in severe inflammatory disease due to uncontrolled IL-12 signaling. Similarly, polymorphisms in SH2B3/LNK that impair its negative regulatory function are associated with hypertension and immune dysregulation.
Cancer and Immune Evasion
Tumors can exploit negative regulation of IL-12 production to evade immune surveillance. Upregulation of PI3K signaling in dendritic cells suppresses IL-12 production, leading to impaired Th1 responses and poor tumor control. Targeting this pathway, for instance with PI3K inhibitors, can restore IL-12 production and enhance anti-tumor immunity.
Infectious Diseases
Pathogens can induce negative regulators of IL-12 to suppress host immunity. For instance, certain parasites and viruses promote SOCS1 expression, which dampens IL-12 production and allows pathogen persistence. Understanding these mechanisms is crucial for vaccine design and immunotherapy.
Cardiovascular and Metabolic Disorders
A single nucleotide polymorphism in SH2B3/LNK that affects its negative regulation of cytokine production, including IL-12, has been linked to hypertension and renal damage. This highlights the broader impact of IL-12 regulation beyond classical immunity.
From negative regulation of interleukin-12 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SOCS1 negatively regulate IL-12 production in dendritic cells? | SOCS1 conditional knockout mice (Cre-lox) |
| What is the effect of a hypertension-associated SH2B3 SNP on IL-12 regulation? | SH2B3 point-mutation knock-in mice |
| Can overexpression of PI3K subunits suppress IL-12 in vivo? | Transgenic mice overexpressing PIK3CD |
| How does TGF-beta signaling repress IL-12 transcription? | TGFB1 knockout or Smad knockout mice |
| Does rapamycin-sensitive mTOR inhibition alter IL-12 production? | mTOR knockout or rapamycin-treated mice |
| What is the role of IL-12 negative regulation in tumor immunity? | B16 melanoma or MC38 colon cancer models in knockout mice |
How to Study the negative regulation of interleukin-12 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Genes whose loss increases IL-12 production | Discovery of novel negative regulators |
| RNA-seq | Transcriptional changes in IL12A/IL12B and pathways | Validation of regulator effects |
| ELISA | Secreted IL-12 protein levels | Quantification in cell culture supernatants |
| Flow cytometry | Intracellular IL-12 and surface markers | Single-cell analysis in immune subsets |
| Western blot | Phosphorylation of STAT4, Akt, etc. | Signaling pathway analysis |
| Phosphoproteomics | Global phosphorylation changes | Mapping kinase networks |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Gain-of-function studies |
| ATAC-seq | Chromatin accessibility at IL12 loci | Epigenetic regulation |
CRISPR-Cas9 Knockout Screens
Genome-wide CRISPR knockout screens can identify novel negative regulators of IL-12 production. By using IL-12 reporter cells or primary dendritic cells, researchers can select for genes whose loss increases IL-12 production. This approach has the power to uncover previously unknown components of the regulatory network.
RNA Sequencing and Transcriptomics
RNA-seq can quantify changes in IL-12 subunit mRNA levels (IL12A, IL12B) and identify co-regulated genes upon perturbation of candidate regulators. Single-cell RNA-seq allows dissection of heterogeneity in IL-12 production across immune cell subsets.
Flow Cytometry and Cytokine Assays
Intracellular cytokine staining and ELISA are standard methods to measure IL-12 protein production at the single-cell and population levels. These techniques are essential for validating findings from genetic screens.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can reveal signaling changes downstream of negative regulators, such as altered phosphorylation of JAK-STAT or PI3K-Akt components. This helps map the molecular mechanisms of suppression.
How CRISPR Can Be Used to Study GO:0032695 negative regulation of interleukin-12 production
Knockout
CRISPR-Cas9 knockout of candidate negative regulators such as SOCS1 or PIK3CD in immune cells or mice can confirm their role in suppressing IL-12 production. For example, SOCS1 knockout macrophages exhibit enhanced IL-12 production upon TLR stimulation.
Point Mutation
Introducing disease-associated point mutations, such as the SH2B3/LNK SNP linked to hypertension, using CRISPR base editing or HDR can model the impact on IL-12 regulation. This allows precise interrogation of variant function.
Knock-in
Knock-in of reporter genes (e.g., GFP) into the IL12B locus enables real-time tracking of IL-12 production in live cells. Additionally, knock-in of epitope tags on regulatory proteins facilitates their study.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high-level expression of negative regulators to test their sufficiency in suppressing IL-12 production. This is useful for validating gain-of-function effects.
How EDITGENE Supports negative regulation of interleukin-12 production Research
Researchers studying negative regulation of interleukin-12 production-related genes often need to determine whether a candidate gene is causally involved in suppressing IL-12, and what the downstream consequences are. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of interleukin-12 production research.
Frequently Asked Questions About negative regulation of interleukin-12 production
What is GO:0032695?
GO:0032695 is the Gene Ontology term for negative regulation of interleukin-12 production, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of IL-12 production.
What genes are involved in negative regulation of interleukin-12 production?
Key genes include SOCS1, PIK3CD, MTOR, SH2B3/LNK, and TGFB1, which suppress IL-12 production through various mechanisms.
How does SOCS1 regulate IL-12 production?
SOCS1 inhibits JAK-STAT signaling downstream of the IL-12 receptor, creating a negative feedback loop that reduces IL-12 production and responsiveness.
What is the role of PI3K in IL-12 regulation?
PI3K mediates negative feedback inhibition of IL-12 production in dendritic cells, partly through Akt and mTOR, ensuring transient IL-12 responses.
How does rapamycin affect IL-12 production?
Rapamycin inhibits mTOR, which relieves a negative regulatory pathway, leading to enhanced IL-12 production.
What diseases are associated with defective negative regulation of IL-12?
Defective negative regulation of IL-12 is linked to autoimmune diseases, chronic inflammation, cancer immune evasion, and hypertension.
What research methods are used to study negative regulation of IL-12 production?
Common methods include CRISPR knockout screens, RNA-seq, ELISA, flow cytometry, and phosphoproteomics.
Can CRISPR be used to study negative regulation of IL-12 production?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are powerful tools to dissect the causal roles of regulators in IL-12 suppression.
What is the role of TGF-beta in IL-12 regulation?
TGF-beta suppresses IL-12 production, contributing to immune tolerance and regulation of Th1 responses.
How does SH2B3/LNK relate to IL-12 and hypertension?
A SNP in SH2B3/LNK that impairs its negative regulatory function is associated with hypertension and altered cytokine production, including IL-12.
Conclusion
Negative regulation of interleukin-12 production (GO:0032695) is a critical biological process that maintains immune balance by preventing excessive Th1 responses. Key regulators such as SOCS1, PI3K, mTOR, and SH2B3/LNK orchestrate this suppression through feedback loops and signaling crosstalk. Dysregulation of this process contributes to autoimmunity, cancer, and cardiovascular disease, making it an attractive therapeutic target. Advances in CRISPR-based models and functional genomics are poised to uncover new layers of regulation and translate these findings into clinical applications.
References
- 1. Eyles JL et al.. 2002. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1.. J Biol Chem 277(46):43735-40 PMID: 12221108
- 2. Ma X et al.. 1998. Positive and negative regulation of interleukin-12 gene expression.. Eur Cytokine Netw 9(3 Suppl):54-64 PMID: 9831187
- 3. Uthaisangsook S et al.. 2003. Negative regulation of interleukin-12 production by a rapamycin-sensitive signaling pathway: a brief communication.. Exp Biol Med (Maywood) 228(9):1023-7 PMID: 14530510
- 4. Fukao T et al.. 2002. PI3K-mediated negative feedback regulation of IL-12 production in DCs.. Nat Immunol 3(9):875-81 PMID: 12154357
- 5. Alexander MR et al.. 2022. A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage.. Circ Res 131(9):731-747 PMID: 36169218
- 6. Fukao T et al.. 2003. PI3K and negative regulation of TLR signaling.. Trends Immunol 24(7):358-63 PMID: 12860525
- 7. Marth T et al.. 1997. Regulation of transforming growth factor-beta production by interleukin-12.. Eur J Immunol 27(5):1213-20 PMID: 9174613
- 8. Trinchieri G. 1997. Function and clinical use of interleukin-12.. Curr Opin Hematol 4(1):59-66 PMID: 9050381
